With a robust background in technology and healthcare investments, the fund manager has successfully led over 50 deals across North America and Europe. Emphasizing an operator-first approach, they have built a portfolio that prioritizes early-stage ventures poised for significant growth. Noteworthy exits highlight their keen ability to identify and nurture transformative companies, particularly in the software and biotech sectors. Their strategic focus on data-driven decision-making ensures a thorough analysis before investment, refining their ability to predict market trends and drive value.